ERBB2 and breast carcinoma: 4. Gelmon K, Walshe JM, Mahtani R, Joy AA, Karuturi M, Neven P, et al. Efficacy and safety of palbociclib in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2. Breast. 2021;59:321-6.